Keyron Medical Technology

🗓 Founded 2016👥 10 employees💰 Last funded May 2024
Medical Equipment Manufacturing🌐 keyron.com
Website LinkedIn
Keyron is a UK- and US-based, preclinical-stage medical device and technology platform company aimed at a highly effective treatment of metabolic diseases. Keyron’s patented ForePass® is an innovative medical device designed to safely reverse type-2 diabetes, as well as NASH, and obesity. The company has already demonstrated a full reversal of insulin resistance in animal studies, and recently published the results in The Lancet EBioMedicine. Keyron has upcoming clinical trials in South America and aims to then carry out further clinical trials in the USA. Its founders, directors, advisors and investors include some of the most well-known and cited professors and KOLs worldwide in the metabolic diseases space. The company is backed by multiple institutional investors based in the USA and EMEA. Keyron is currently fundraising for a $7.5m Series A investment round. Please contact our CEO, Carl D. Francis (c.francis@keyron.com) for investment enquiries. Disclaimer: This is not a solicitation of investment.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Switzerland
1
Germany
1
Frequently asked questions
Who invested in Keyron Medical Technology?
Keyron Medical Technology has 2 investors on record on gritt.io and 2 late-stage investors.
When did Keyron Medical Technology last raise funding?
The most recent investment in Keyron Medical Technology recorded on gritt.io was in May 2024.
When was Keyron Medical Technology founded?
Keyron Medical Technology was founded in 2016.
What industry is Keyron Medical Technology in?
Keyron Medical Technology operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.